Status:

TERMINATED

Managed Ventricular Pacing ("MVP") Trial

Lead Sponsor:

Medtronic Cardiac Rhythm and Heart Failure

Collaborating Sponsors:

Medtronic

Conditions:

Heart Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of the study is to compare two device settings (sets of instructions) used by the ICD. The Implantable Cardiac Defibrillator ("ICD") can be set to use one wire (top or bottom of the heart)...

Detailed Description

Recent research supports the hypothesis that reducing the amount of pacing in the lower right chamber of the heart may prevent the progression of congestive heart failure (CHF) in some implantable car...

Eligibility Criteria

Inclusion

  • Conventional indication for ICD therapy according to current evidence-based guidelines and in accordance with the corresponding United States Centers for Medicare and Medicaid Services National Coverage Determination for the use of ICDs.
  • Prior myocardial infarction ("MI") and an left ventricular ejection fraction ("LVEF") of less than 30%
  • Ischemic Dilated Cardiomyopathy (IDCM), New York Heart Association ("NYHA") Class II or II heart failure, and LVEF less than or equal to 35%
  • Non-Ischemic Dilated Cardiomyopathy (NIDCM) greater than 3 months, NYHA Class II or II heart failure, and LVEF less than or equal to 35%
  • First ICD implant
  • Successful implant with a study device with approved labeling

Exclusion

  • Failure to meet any of the inclusion criteria
  • Class I pacing indication
  • Chronic atrial fibrillation ("AF") without any documented sinus mechanism for at least 6 months
  • Inability or unwillingness to give informed consent
  • Life expectancy less than 12 months or a heart transplant anticipated within 6 months
  • Inability to successfully comply with study participation and follow up requirements
  • Patient involved in another clinical trial that may confound the results of the study

Key Trial Info

Start Date :

October 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2008

Estimated Enrollment :

1031 Patients enrolled

Trial Details

Trial ID

NCT00281099

Start Date

October 1 2004

End Date

July 1 2008

Last Update

August 3 2010

Active Locations (73)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 19 (73 locations)

1

Anchorage, Alaska, United States

2

Little Rock, Arkansas, United States

3

North Little Rock, Arkansas, United States

4

Brandon, Florida, United States